To compare the efficacy and safety of Rosuvastatin, Atorvastatin and Pravastatin among dyslipidemic diabetic patients at a tertiary centre in Bihar . Journal of Pharmaceutical Negative Results, [S. l.], p. 672–676, 2023. DOI: 10.47750/pnr.2023.14.03.087. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/8097.. Acesso em: 13 jun. 2026.